X4 Pharmaceuticals, Inc. (XFOR)

X4 Pharmaceuticals Revenue

X4 Pharmaceuticals had revenue of $2.71M in the quarter ending March 31, 2026, a decrease of -90.60%. This brings the company's revenue in the last twelve months to $9.01M, down -71.26% year-over-year. In the year 2025, X4 Pharmaceuticals had annual revenue of $35.11M with 1,273.21% growth.

• Revenue (ttm): $9.01M
• Revenue Growth: -71.26%
• P/S Ratio: 45.79
• Revenue / Employee: $200,311
• Employees: 45
• Market Cap: 402.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.11M	32.56M	1,273.21%
Dec 31, 2024	2.56M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error